Viemed Healthcare, Inc. (VMD)
USD 7.07
(0.0%)
USD 7.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 14.33 Million USD | 91.44% |
| 2022 | 8.25 Million USD | -28.74% |
| 2021 | 11.58 Million USD | -56.76% |
| 2020 | 26.78 Million USD | 206.17% |
| 2019 | 8.74 Million USD | -48.68% |
| 2018 | 17.04 Million USD | 93.17% |
| 2017 | 8.82 Million USD | 2203.92% |
| 2016 | 383 Thousand USD | -96.18% |
| 2015 | 10.03 Million USD | 5.81% |
| 2014 | 9.48 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.29 Million USD | 49.36% |
| 2024 Q1 | 2.2 Million USD | -61.85% |
| 2023 Q2 | 2.9 Million USD | 50.0% |
| 2023 Q1 | 1.93 Million USD | -45.27% |
| 2023 Q4 | 5.77 Million USD | 37.36% |
| 2023 Q3 | 4.2 Million USD | 44.98% |
| 2023 FY | 15.79 Million USD | 91.44% |
| 2022 Q3 | 1.46 Million USD | 46.75% |
| 2022 Q4 | 3.53 Million USD | 140.57% |
| 2022 FY | 8.25 Million USD | -28.74% |
| 2022 Q1 | 2.24 Million USD | -51.81% |
| 2022 Q2 | 1 Million USD | -55.47% |
| 2021 Q4 | 4.66 Million USD | 59.82% |
| 2021 Q3 | 2.91 Million USD | 9.57% |
| 2021 Q2 | 2.66 Million USD | 100.0% |
| 2021 FY | 11.58 Million USD | -56.76% |
| 2021 Q1 | 1.33 Million USD | -74.71% |
| 2020 Q4 | 5.26 Million USD | 30.37% |
| 2020 FY | 26.78 Million USD | 206.17% |
| 2020 Q3 | 4.04 Million USD | -68.58% |
| 2020 Q2 | 12.85 Million USD | 178.63% |
| 2020 Q1 | 4.61 Million USD | 73.63% |
| 2019 Q1 | 4.69 Million USD | -1.7% |
| 2019 FY | 8.74 Million USD | -48.68% |
| 2019 Q4 | 2.65 Million USD | 17.25% |
| 2019 Q3 | 2.26 Million USD | 6.33% |
| 2019 Q2 | 2.13 Million USD | -54.56% |
| 2018 Q2 | 3.76 Million USD | -6.45% |
| 2018 Q3 | 4.47 Million USD | 18.79% |
| 2018 Q4 | 4.77 Million USD | 6.64% |
| 2018 FY | 17.04 Million USD | 93.17% |
| 2018 Q1 | 4.02 Million USD | 127.83% |
| 2017 FY | 8.82 Million USD | 2203.92% |
| 2017 Q2 | 3.15 Million USD | -17.0% |
| 2017 Q1 | 3.79 Million USD | 110.6% |
| 2017 Q3 | 5.25 Million USD | 66.76% |
| 2017 Q4 | 1.76 Million USD | -66.34% |
| 2016 Q4 | 1.8 Million USD | 256.83% |
| 2016 Q3 | 505 Thousand USD | 0.0% |
| 2016 FY | 383 Thousand USD | -96.18% |
| 2015 FY | 10.03 Million USD | 5.81% |
| 2014 FY | 9.48 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 199.784% |
| Cerus Corporation | -30.05 Million USD | 147.682% |
| OrthoPediatrics Corp. | -25.76 Million USD | 155.616% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 234.917% |
| Talis Biomedical Corporation | -66.81 Million USD | 121.447% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 182.852% |
| Inogen, Inc. | -109.38 Million USD | 113.1% |
| Spectral AI, Inc. | -12.98 Million USD | 210.367% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 122.895% |
| CVRx, Inc. | -43.1 Million USD | 133.246% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 506.179% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 215.304% |
| Orthofix Medical Inc. | -139.11 Million USD | 110.301% |
| Venus Concept Inc. | -28.3 Million USD | 150.62% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 126.523% |
| Bioventus Inc. | -81.72 Million USD | 117.534% |
| BrainsWay Ltd. | -4.92 Million USD | 390.846% |
| Envoy Medical, Inc. | -18.37 Million USD | 178.003% |
| electroCore, Inc. | -18.8 Million USD | 176.203% |
| IceCure Medical Ltd | -15.57 Million USD | 192.001% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 129.557% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 182.986% |
| MaxCyte, Inc. | -48.29 Million USD | 129.669% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 219.864% |
| Nexalin Technology, Inc. | -5.69 Million USD | 351.567% |
| PAVmed Inc | -68.79 Million USD | 120.83% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 125.335% |
| RxSight, Inc. | -50.08 Million USD | 128.611% |
| Sight Sciences, Inc. | -57.27 Million USD | 125.02% |
| SI-BONE, Inc. | -46.93 Million USD | 130.534% |
| TELA Bio, Inc. | -44.07 Million USD | 132.513% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 126.464% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 127.864% |
| LivaNova PLC | -68.49 Million USD | 120.92% |
| 908 Devices Inc. | -42.75 Million USD | 133.514% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 108.264% |
| Nemaura Medical Inc. | -9.59 Million USD | 249.345% |
| NeuroPace, Inc. | -27.17 Million USD | 152.734% |
| LENSAR, Inc. | -12.22 Million USD | 217.18% |
| Apyx Medical Corporation | -17.25 Million USD | 183.029% |
| Cutera, Inc. | -156.23 Million USD | 109.172% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 266.55% |
| BioSig Technologies, Inc. | -28.51 Million USD | 150.26% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 116.351% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 163.842% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 87.151% |
| Axonics, Inc. | -26.05 Million USD | 154.995% |
| Outset Medical, Inc. | -169.77 Million USD | 108.441% |
| IRIDEX Corporation | -10 Million USD | 243.2% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 113.126% |
| IRadimed Corporation | 20.03 Million USD | 28.477% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 273.802% |
| INVO Bioscience, Inc. | -6.76 Million USD | 311.758% |
| Telesis Bio, Inc. | -35.15 Million USD | 140.768% |
| Varex Imaging Corporation | 32.1 Million USD | 55.358% |
| Quipt Home Medical Corp. | 3.91 Million USD | -265.655% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 218.108% |
| Pulmonx Corporation | -61.93 Million USD | 123.137% |
| Dynatronics Corporation | -2.27 Million USD | 730.431% |
| Modular Medical, Inc. | -17.52 Million USD | 181.75% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 197.889% |
| Semler Scientific, Inc. | 22.25 Million USD | 35.613% |
| InMode Ltd. | 195.66 Million USD | 92.676% |
| Bruker Corporation | 436.9 Million USD | 96.72% |
| Cytosorbents Corporation | -31.2 Million USD | 145.916% |
| DexCom, Inc. | 597.7 Million USD | 97.602% |
| Align Technology, Inc. | 643.33 Million USD | 97.773% |
| Viveve Medical, Inc. | -21.55 Million USD | 166.487% |
| ZimVie Inc. | -30.93 Million USD | 146.317% |
| Movano Inc. | -29.69 Million USD | 148.265% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 151.463% |
| Nexalin Technology, Inc. | -5.69 Million USD | 351.567% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 506.179% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 106.144% |
| Profound Medical Corp. | -28.61 Million USD | 150.077% |
| Insulet Corporation | 220 Million USD | 93.486% |
| enVVeno Medical Corporation | -25.23 Million USD | 156.779% |
| Surmodics, Inc. | -5.64 Million USD | 353.853% |
| iCAD, Inc. | -7.68 Million USD | 286.37% |
| Nuwellis, Inc. | -17.63 Million USD | 181.282% |
| Biotricity, Inc. | -8.82 Million USD | 262.319% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 111.449% |
| Aethlon Medical, Inc. | -12.63 Million USD | 213.401% |
| InspireMD, Inc. | -21.14 Million USD | 167.777% |
| PAVmed Inc. | -68.79 Million USD | 120.83% |
| BIOLASE, Inc. | -17.93 Million USD | 179.891% |
| Beyond Air, Inc. | -63 Million USD | 122.744% |
| FONAR Corporation | 16.53 Million USD | 13.337% |
| AxoGen, Inc. | -21.46 Million USD | 166.769% |
| Vivani Medical, Inc. | -26.96 Million USD | 153.143% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 20.57% |
| Inari Medical, Inc. | -14.03 Million USD | 202.124% |
| UFP Technologies, Inc. | 57.66 Million USD | 75.149% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 390.811% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 327.252% |
| Tenon Medical, Inc. | -15.72 Million USD | 191.117% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 291.731% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 133.555% |
| AdaptHealth Corp. | -598.4 Million USD | 102.395% |
| Sintx Technologies, Inc. | -13.35 Million USD | 207.277% |
| NanoVibronix, Inc. | -3.43 Million USD | 517.055% |
| Quanterix Corporation | -49.7 Million USD | 128.832% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 218.108% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 3851.309% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 104.284% |
| TransMedics Group, Inc. | -28.72 Million USD | 149.883% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 160.689% |
| NeuroMetrix, Inc. | -7.15 Million USD | 300.377% |
| Hyperfine, Inc. | -48.11 Million USD | 129.783% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 122.037% |
| Biomerica, Inc. | -6.36 Million USD | 325.067% |
| Bone Biologics Corporation | -9.42 Million USD | 251.989% |
| AVITA Medical, Inc. | -40.4 Million USD | 135.468% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 238.975% |
| Silk Road Medical, Inc | -59.27 Million USD | 124.177% |